SCHEMBL2908455

SCHEMBL2908455

COC1CC(N2CCCC(O)C2)CCc2ccc(N)cc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
DRD1 P21728 1/20 0.35
CCR4 P51679 1/20 0.34
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
SLC6A4 P31645 1/20 0.32
KDM2B Q8NHM5 2/20 0.32
KCNA5 P22460 5/20 0.31
SCN5A Q14524 5/20 0.31
KCND2 Q9NZV8 5/20 0.31
KCNH2 Q12809 1/20 0.31
BRD4 O60885 1/20 0.31
ATAD2 Q6PL18 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913227 0.82 DRD2 (0.40) DRD2HTR2A
SCHEMBL2479144 0.79 DRD1 (0.35) DRD2HTR2ADRD1SLC6A4BRD4
SCHEMBL2915586 0.79 DRD1 (0.35) DRD2HTR2ADRD1SLC6A4BRD4
SCHEMBL17729306 0.72 IDO1 (0.42) DRD2HTR2ADRD1SLC6A4
SCHEMBL2060941 0.70 CCR4 (0.35) CCR4DPP4DPP8DPP9KDM2B
SCHEMBL2908453 0.67 HRH3 (0.45) DPP4DPP8DPP9KDM2B
SCHEMBL4294921 0.65 USP30 (0.41) KCNH2
SCHEMBL24717540 0.65 HRH3 (0.34) CCR4DPP4DPP8DPP9KDM2B
SCHEMBL24717539 0.65 HRH3 (0.34) CCR4DPP4DPP8DPP9KDM2B
SCHEMBL7008801 0.64 CHRNA7 (0.53) BRD4ATAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed